Validation of a Model for Predicting Anastomotic Leakage
Validation of a Machine Learning Model for Predicting Anastomotic Leakage of Esophagogastrostomy and Esophagojejunostomy: A Multicenter Prospective Study
1 other identifier
observational
512
1 country
1
Brief Summary
This study will validate a machine learning model for predicting anastomotic leakage of esophagogastrostomy and esophagojejunostomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2022
CompletedFirst Submitted
Initial submission to the registry
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2024
CompletedNovember 21, 2024
November 1, 2024
2.2 years
December 1, 2022
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of anastomotic leakage
Within 30 days after operation
Eligibility Criteria
Gastric cancer patients undergoing total or proximal gastrectomy in five medical centers (Tongji Hospital, Wuhan No. 1 Hospital, Xianning Central Hospital, Huanggang Central Hospital and Jingzhou Central Hospital) are included in this perspective study.
You may qualify if:
- Aged older than 18 years and younger than 85 years.
- Primary gastric adenocarcinoma confirmed by preoperative pathology.
- Expected curative resection via total or proximal gastrectomy.
- American Society of Anesthesiologists (ASA) class I, II, or III.
- Written informed consent.
You may not qualify if:
- Pregnant or breastfeeding women.
- Severe mental disorder or language communication disorder.
- Other surgical procedures of gastrectomy is performed.
- Interrupted of surgery for more than 30 minutes due to any cause.
- Malignant tumors with other organs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jichao Qinlead
Study Sites (1)
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, 430030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 1, 2022
First Posted
December 12, 2022
Study Start
January 6, 2022
Primary Completion
March 15, 2024
Study Completion
May 6, 2024
Last Updated
November 21, 2024
Record last verified: 2024-11